Kendall S. Frazier

Independent Sector — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

27h-index3.9kcitations535works0.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Metabolism and Genetic Disorders(27), Pulmonary Hypertension Research and Treatments(22), Congenital Heart Disease Studies(17), Porphyrin Metabolism and Disorders(12), Genomic variations and chromosomal abnormalities(10)

Publications535 total

RNA-based therapeutic opportunities for the treatment of kidney diseases
Nature Reviews Nephrology·2025· 2 cited
Urinary System
Toxicologic Pathology·2025
Contributors
Elsevier eBooks·2025
Kidney
Elsevier eBooks·2025
Urinary System
Toxicologic Pathology·2024
Gabapentin use in the neonatal intensive care unit and beyond: Single center report of 104 cases
Journal of Neonatal-Perinatal Medicine·2023· 2 cited
Kidney Effects by Alternative Classes of Medicines in Patients and Relationship to Effects in Nonclinical Toxicity Studies
Toxicologic Pathology·2022· 4 cited
Differential uptake of antisense oligonucleotides in mouse hepatocytes and macrophages revealed by simultaneous 2P-fluorescence and coherent Raman imaging
2022
Differential Uptake of Antisense Oligonucleotides in Mouse Hepatocytes and Macrophages Revealed by Simultaneous Two-Photon Excited Fluorescence and Coherent Raman Imaging
Nucleic Acid Therapeutics·2021· 12 citedOpen Access
The Impact of Functional and Structural Maturation of the Kidney on Susceptibility to Drug and Chemical Toxicity in Neonatal Rodents
Toxicologic Pathology·2021· 5 cited
A Review of Specific Biomarkers of Chronic Renal Injury and Their Potential Application in Nonclinical Safety Assessment Studies
Toxicologic Pathology·2021· 59 citedOpen Access
Congenital Unilateral Renal Aplasia in a Cynomolgus Monkey (<i>Macaca fascicularis</i>) With Investigation Into Potential Pathogenesis
Toxicologic Pathology·2020· 2 citedOpen Access
Scientific Regulatory Policy Committee Points to Consider*: Nuisance Factors, Block Effects, and Batch Effects in Nonclinical Safety Assessment Studies
Toxicologic Pathology·2020· 11 citedOpen Access
Ontogeny and Cross-species Comparison of Pathways Involved in Drug Absorption, Distribution, Metabolism, and Excretion in Neonates (Review): Kidney
Drug Metabolism and Disposition·2020· 37 citedOpen Access
Supplemental Material, sj-docx-1-tpx-10.1177_0192623320906385 - Scientific Regulatory Policy Committee Points to Consider*: Nuisance Factors, Block Effects, and Batch Effects in Nonclinical Safety Assessment Studies
Figshare·2020Open Access
Carcinogenicity Assessment of Daprodustat (GSK1278863), a Hypoxia-Inducible Factor (HIF)-Prolyl Hydroxylase Inhibitor
Toxicologic Pathology·2019· 27 cited
Intrarenal Renin–Angiotensin System Involvement in the Pathogenesis of Chronic Progressive Nephropathy—Bridging the Informational Gap Between Disciplines
Toxicologic Pathology·2019· 13 citedOpen Access
Renal Papillary Rarefaction: An Artifact Mimicking Papillary Necrosis
Toxicologic Pathology·2019· 8 cited
Drug safety Africa: An overview of safety pharmacology &amp; toxicology in South Africa
Journal of Pharmacological and Toxicological Methods·2019· 2 citedOpen Access
Kidney Pathology and Investigative Nephrotoxicology Strategies Across Species
Seminars in Nephrology·2019· 10 cited
page 1 of 27Next →

Frequent Co-authors

Alexander K. C. Leung(22), Silke Hofmann(18), Leena Bruckner‐Tuderman(18), Alexander K. C. Leung(14), Markus Braun‐Falco(12), Markus Böhm(12), Thomas A. Luger(12), William Lane M. Robson(12), Marshall S. Scicchitano(10), Sharon L. Wenger(6), Stephan DiSean Kendall(6), Gerard C. Blobe(6), Christoph K. Weber(6), Richard Lorenz(6), Guido Adler(6), David C. Whitcomb(6), Dhiraj Yadav(6), Johannes G. Bode(6), Martin Wabitsch(6), Klaus‐Michael Debatin(6)